In support of this, evidence showed that FGF2 is overexpressed in VSMCs from COPD patients; whereas in another study, FGF2 promotes a proinflammatory phenotype of VSMCs through increasing cellular IL-1α secretion (Schultz et al., 2007). The gene discussed is FGF2; the disease is chronic obstructive pulmonary disease.